MILAN, ITALY — Amplifon is taking another step toward completing its proposed acquisition of GN Hearing, with the company’s Board of Directors moving to call a shareholders’ meeting to approve the issuance of 56 million new Amplifon shares to GN Store Nord as part of the transaction....
Continue reading at Hearing Health Matters
✦ The floor
Discussion
Signed responses from readers of the wire.
No actionable change for clinical practice; this is a corporate acquisition financing step with no immediate impact on patient care or clinical protocols.
A completed Amplifon–GN Hearing merger would create one of the most vertically integrated companies in audiology, potentially reshaping product distribution, brand availability, and competitive dynamics for independent clinics worldwide.
- 01Amplifon's board has called a shareholders' meeting to vote on issuing 56 million new shares to GN Store Nord.
- 02The share issuance is part of the financing structure for Amplifon's proposed acquisition of GN Hearing.
- 03GN Hearing is the manufacturer behind the ReSound and Jabra hearing aid brands.
- 04The deal would vertically integrate a top-tier hearing aid manufacturer with the world's largest retail hearing care network.
- 05Shareholder approval is a required regulatory/corporate step before the transaction can close.
Amplifon's Board of Directors has called a shareholders' meeting to approve the issuance of 56 million new shares to GN Store Nord.
press releasesupportedThe share issuance is part of Amplifon's proposed acquisition of GN Hearing.
press releasesupported
